Kewaunee Scientific reports FY2026 revenue up 17.3% to $282M; EPS down to $3.22 from $3.83

KEWAUNEE SCIENTIFIC CORP /DE/

Full-year sales $281.999M (+17.3% YoY); net earnings $9.618M vs $11.405M prior year.
Diluted EPS $3.22 compared to $3.83; EBITDA $22.425M vs $21.613M.
Lab Products Group segment sales $214.886M (+19.8%), net earnings $14.156M vs $15.370M.
Company cites challenging market conditions including tariff costs, partly offset by productivity gains.
Nu Aire integration and balance sheet improvement noted as positives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.